[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BioctiN NioctiB NioctiB posts on X about $rls, bitget, binance, okx the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::1477226402269122560/interactions)  - X Week XXX +1,003% - X Month XXX +1,161% - X Months XXX +8,682% - X Year XXXXX +1,351% ### Mentions: X [#](/creator/twitter::1477226402269122560/posts_active)  - X Week XX +420% - X Month XX +700% - X Months XX +1,700% - X Year XX +875% ### Followers: XX [#](/creator/twitter::1477226402269122560/followers)  - X Week XX +7.70% - X Month XX +115% - X Months XX +367% ### CreatorRank: undefined [#](/creator/twitter::1477226402269122560/influencer_rank)  ### Social Influence [#](/creator/twitter::1477226402269122560/influence) --- **Social category influence** [exchanges](/list/exchanges) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$rls](/topic/$rls) 3.85%, [bitget](/topic/bitget) 3.85%, [binance](/topic/binance) 3.85%, [okx](/topic/okx) 3.85%, [bithumb](/topic/bithumb) 3.85%, [the original](/topic/the-original) 3.85%, [cryptonews](/topic/cryptonews) 3.85%, [$hype](/topic/$hype) 3.85%, [hyperliquid](/topic/hyperliquid) 3.85%, [token](/topic/token) XXXX% **Top accounts mentioned or mentioned by** [@vanct20](/creator/undefined) [@edgentech](/creator/undefined) [@raylslabs](/creator/undefined) [@bitgetglobal](/creator/undefined) **Top assets mentioned** [Hyperliquid (HYPE)](/topic/$hype) [Ethereum (ETH)](/topic/$eth) ### Top Social Posts [#](/creator/twitter::1477226402269122560/posts) --- Top posts by engagements in the last XX hours "🚨 Big surprise from the Rayls community $RLS smart contract just appeared on Bitget TGE might move up from Q1 2026 to Nov 2025 a 4-month leap Early supporters could be in for a wild ride. Next stop: Binance OKX or Bithumb #Rayls #Bitget #CryptoNews #ListingRumor" [X Link](https://x.com/BioctiN/status/1982234279321939985) [@BioctiN](/creator/x/BioctiN) 2025-10-25T23:54Z XX followers, XXX engagements "Hyperliquid ($HYPE) the boldest on-chain exchange yet. Own L1. CEX-speed order book. Built by ex-HFT engineers no VC strings. Next: XX% burn token unlocks ETF rumors. If it delivers game changer. ⚡ #HYPE @EdgenTech $ETH" [X Link](https://x.com/BioctiN/status/1982237231432577386) [@BioctiN](/creator/x/BioctiN) 2025-10-26T00:05Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioctiN NioctiBNioctiB posts on X about $rls, bitget, binance, okx the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours.
Social category influence exchanges XXXX% cryptocurrencies XXXX% finance XXXX%
Social topic influence $rls 3.85%, bitget 3.85%, binance 3.85%, okx 3.85%, bithumb 3.85%, the original 3.85%, cryptonews 3.85%, $hype 3.85%, hyperliquid 3.85%, token XXXX%
Top accounts mentioned or mentioned by @vanct20 @edgentech @raylslabs @bitgetglobal
Top assets mentioned Hyperliquid (HYPE) Ethereum (ETH)
Top posts by engagements in the last XX hours
"🚨 Big surprise from the Rayls community $RLS smart contract just appeared on Bitget TGE might move up from Q1 2026 to Nov 2025 a 4-month leap Early supporters could be in for a wild ride. Next stop: Binance OKX or Bithumb #Rayls #Bitget #CryptoNews #ListingRumor"
X Link @BioctiN 2025-10-25T23:54Z XX followers, XXX engagements
"Hyperliquid ($HYPE) the boldest on-chain exchange yet. Own L1. CEX-speed order book. Built by ex-HFT engineers no VC strings. Next: XX% burn token unlocks ETF rumors. If it delivers game changer. âš¡ #HYPE @EdgenTech $ETH"
X Link @BioctiN 2025-10-26T00:05Z XX followers, XX engagements
/creator/x::BioctiN